Nancy A Simonian

CIK 1359574 · President & CEO · last filed 2026-03-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$34

Companies

5

Total Filings

50

Lifetime Open-Market Net

-$2.15M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GENB Director $12.38 $0 1 2026-03-02
SYRS Director 84,000 $0.00 $34 -$45.8K 22 2024-12-04
Seagen Inc. (SGEN) Delisted Director 0 $228.74 $0 $0 14 2023-12-15
EVLO Director $0.00 $0 3 2020-06-18
MILLENNIUM PHARMACEUTICALS INC (MLNM) Delisted Chief Medical Officer 4,975 -$2.10M 6 2008-05-15

Recent Filings · Page 2 of 5

50 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-04-04 SYRS Mixed +4,148 -$4.8K EDGAR
2023-02-21 SYRS Grant (A) $0 EDGAR
2022-12-14 Seagen Inc. (SGEN) Delisted Exer (M) +8,750 $321.1K EDGAR
2022-10-11 SYRS Grant (A) $0 EDGAR
2022-05-17 Seagen Inc. (SGEN) Delisted Grant (A) +1,503 $0 EDGAR
2022-04-04 SYRS Tax (F) −58,883 -$65.9K EDGAR
2022-03-04 Seagen Inc. (SGEN) Delisted Exer (M) +25,000 $501.0K EDGAR
2022-02-17 SYRS Grant (A) $0 EDGAR
2021-05-18 Seagen Inc. (SGEN) Delisted Grant (A) +1,402 $0 EDGAR
2021-02-19 SYRS Grant (A) $0 EDGAR
Showing 1120 of 50
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.